Know to all, traditional chemotherapy or emanation cancer treatment the method will also bring injury to normal cell at the time of killing cancer cell and return easy creation side effect or cause patient's resistibility turn down.However now, a kind of the new medicine that can resist a leukemia will soon publish!Had it, the leukemia sufferer canned no longer depend on a chemotherapy or project therapy to cure cancer.And, pass a clinical trial, the miraculous curative effect of this kind of medicine got numerous experts approbation and affirmation.
According to Reuter's December be 5, recently, on the meeting of American blood academic association(the of Hematology of the American Society), relevant researcher's introducing is called the new medicine of BMS-354825, and reported it the good curative effect obtain is in the clinical trial.
BMS-354825 from 100:00 United States in the United States-Shi Gui4 Bao3's company(Bristol-Myers Squibb) development develop.At the clinical trial stage, the experts carried on to experiment to 36 leukemia sufferers.Show that pass takes this kind of medicine as a result, 86% sufferers tumors all appeared to disappear an evidence.
Although BMS-354825 of experiment still be placed in the first stage of clinical trial so far, , above-mentioned experiment result of announce to still lead the academic circles one be shocked with praise.
The vice- chairman of the American leukemia and lymphoid lump association(the and Lymphoma of the The Leukemia Society) moxa Lun gave the very high evaluation of the BMS-354825 more.He say:"This medicine is absolutely too good and having it us will can save more lifes!"
The BMS-354825 develops success, let people can not help remind of is in 2001 develop by Switzerland promise Hua pharmaceutical factory(Novartis) and release of the same kind medicine Gleevec.At that year, the Gleevec emergence caused people tremendous concern.Because before it appear, didn't°yet any medicine slice can obtain and chemotherapy and project the therapy equally good curative effect.
Gleevec main function, is pass it with body inside of the cell of BCR-ABL Mao combine, bar movable sex of that cell, thus and betterly obstruct growth and proliferation of cancer cell.However, the researcher afterwards discovers, the Gleevec has a very strong drug-resistant, because pass to carry on following inquisition to the sufferer who takes Gleevec, detection about 12% sufferer's bodies appeared relapse of cancer cell.
So, the BMS-354825 of new birth is BE not can be easy to make up Gleevec of weakness?The reporter of the Reuter's covered American Huo Hua to rest the Si medical science Er Si in the check of graduate school(the Medical Institute of the Howard Hughes) a professor for this problem.
Check the professor of Er Si said, he also worried that this kind of new medicine will appear some side effect with colleague.However, see from the current circumstance, this kind of medicine is still very safe.And, this time new medicine for develop's ising not a Gleevec is 2 and it has different chemistry structure.
Certainly checked Er Si a professor to return the usage toward the medicine to some suggestions, he hoped that people are take a medicine of also want to match with the chemistry treatment of tradition in the meantime.Because so far didn't°yet whichever case, can prove to depend on alone take the medicine can to the root repress tumor of growth.
Another according to know, the promise turns a company to also release a kind of medicine of new treatment leukemia, it is said that it also equally made up Gleevec weakness.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment